84 related articles for article (PubMed ID: 20188757)
1. CD40 signaling activated by agonistic anti-CD40 monoclonal antibody 5C11 has different effects on biological behavior of gastric carcinoma cells.
Li R; Chen WC; Wang WP; Tian WY; Zhang XG
Immunol Lett; 2010 Jul; 131(2):120-5. PubMed ID: 20188757
[TBL] [Abstract][Full Text] [Related]
2. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells.
Qi CJ; Zheng L; Zhou X; Tao Y; Ge Y; Zhuang YM; Xu Y; Yu G; Zhang XG
Immunol Lett; 2004 May; 93(2-3):151-8. PubMed ID: 15158611
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of multiple myeloma and B lymphoma lines to dexamethasone and gamma-radiation-induced apoptosis by CD40 activation.
Zhou ZH; Shi Q; Wang JF; Chen YJ; Zhuang YM; Pan JZ; Xu CS; Qi CJ; Zhang XG
Apoptosis; 2005 Jan; 10(1):123-34. PubMed ID: 15711928
[TBL] [Abstract][Full Text] [Related]
4. CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line.
Fujieda S; Sugimoto C; Seki M; Sunaga H; Saito H
Oncol Res; 1998; 10(9):433-9. PubMed ID: 10223618
[TBL] [Abstract][Full Text] [Related]
5. Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells.
Zhou XX; Ji F; Zhao JL; Cheng LF; Xu CF
J Gastroenterol Hepatol; 2010 Jul; 25(7):1266-75. PubMed ID: 20594254
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD40 and growth-inhibitory activity of CD40 ligand in colon cancer ex vivo.
Wu Y; Wang L; He X; Xu H; Zhou L; Zhao F; Zhang Y
Cell Immunol; 2008; 253(1-2):102-9. PubMed ID: 18603231
[TBL] [Abstract][Full Text] [Related]
7. A novel blocking monoclonal antibody recognizing a distinct epitope of human CD40 molecule.
Zhuang Y; Huang J; Zhou Z; Ge Y; Fan Y; Qi C; Zhen L; Monchatre E; Edelman L; Zhang X
Tissue Antigens; 2005 Jan; 65(1):81-7. PubMed ID: 15663744
[TBL] [Abstract][Full Text] [Related]
8. Preclinical antilymphoma activity of a humanized anti-CD40 monoclonal antibody, SGN-40.
Law CL; Gordon KA; Collier J; Klussman K; McEarchern JA; Cerveny CG; Mixan BJ; Lee WP; Lin Z; Valdez P; Wahl AF; Grewal IS
Cancer Res; 2005 Sep; 65(18):8331-8. PubMed ID: 16166310
[TBL] [Abstract][Full Text] [Related]
9. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
11. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
Liu P; Wang TS; You SH; Ge HM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
[TBL] [Abstract][Full Text] [Related]
12. Ligation or cross-linking of CD40 has different effects on AGS gastric cancer cells.
Qi CJ; Qian KQ; Ning YL; Ma HB; Wang SZ; Zhang XG
Cell Immunol; 2009; 259(2):135-40. PubMed ID: 19604505
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lung cancer cell proliferation by CD40 signaling through tumor necrosis factor I.
Lu XD; Zhu XL; Chen C; Zhang GB; Zhang XG; Huang JA
Ai Zheng; 2009 Jan; 28(1):20-3. PubMed ID: 19448410
[TBL] [Abstract][Full Text] [Related]
15. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
Kim R; Tanabe K; Inoue H; Toge T
Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.
Péguet-Navarro J; Dalbiez-Gauthier C; Moulon C; Berthier O; Réano A; Gaucherand M; Banchereau J; Rousset F; Schmitt D
J Immunol; 1997 Jan; 158(1):144-52. PubMed ID: 8977185
[TBL] [Abstract][Full Text] [Related]
17. [Expression of gastrin in human gastric cancer cell line and effect of anti-gastrin mAb on the cell growth].
Wang X; Wei DP; Cai MY
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):276-8. PubMed ID: 15996318
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a novel chimeric antibody against human CD40 with the potential to inhibit Daudi cell proliferation.
Qu QX; Ge Y; Chen YJ; Chen C; Qiu YH; Zhang XG
Hybridoma (Larchmt); 2009 Apr; 28(2):121-8. PubMed ID: 19382845
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
[TBL] [Abstract][Full Text] [Related]
20. An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line.
Zhou ZH; Wang JF; Wang YD; Qiu YH; Pan JZ; Xie W; Jiang LY; Klein B; Zhang XG
Hybridoma; 1999 Dec; 18(6):471-8. PubMed ID: 10626675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
